Endocrinology News

When I first entered the medical profession more than 30 years ago, I was taken by the amount of trash that was produced in the emergency department where I volunteered.

More than half of adults with acromegaly receiving a novel once-daily oral medication achieved an insulin-like growth factor-1 level at or below the upper limit of normal, according to topline results from the PATHFNDR-2 trial.

Susan Weiner, MS, RDN, CDCES, FADCES, talks with Lauren Plunkett, RDN, LD, CDCES, about benefits of plant-based nutrition for people with diabetes and strategies for incorporating whole foods and plants into eating plans.

The CDC published a guide that hospitals can use to reduce the risk for burnout among health care staff.

A once-weekly basal insulin conferred similar changes in HbA1c and time in range as once-daily insulin glargine among adults with type 1 and type 2 diabetes in three phase 2 trials, according to a speaker.

The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release.

Hormone therapy was associated with an improved weight-loss response for postmenopausal women with overweight or obesity treated with semaglutide, according to cohort study results published in Menopause.

An op-ed published in February by Tom Frieden, MD, MPH, former director of the CDC, described hypertension as “the deadliest but most neglected and widespread pandemic of our time” — and he’s right.

An automated insulin delivery system controlled by an artificial intelligence machine learning model may perform just as well as a system using a traditional equation-based insulin dosing algorithm, according to a speaker.

Patients who eventually developed giant cell arteritis demonstrated significantly higher levels of apolipoprotein A-I at baseline, according to population-based data published in Arthritis Research & Therapy.